Oncology Index
Leverage Industry-Leading Oncology Market Research
- View Payer Management Behavior in Oncology: Analyze current payer management strategies for specific oncology brands, including prioritization of indications and coverage decisions across plans.
- Create Payer Profiles from Real-World Insights: Build detailed payer profiles using unblinded responses to uncover management trends, decision-making patterns, and access strategies.
- Observe Coverage Trends Across Commercial and Medicare Payers: Track anticipated coverage changes over time across key Commercial and Medicare payer organizations to stay ahead of market shifts.
- Understand Payer and IDN Dynamics in Oncology: Gain insight into the evolving relationships between payers and IDNs to understand how they influence oncology treatment.
Stay Ahead of Oncology Market Access Trends
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
We deliver quarterly reports that spotlight the latest and emerging access restrictions across targeted oncology therapeutic areas. These comprehensive insights help your team refine both national and regional strategies, transforming directional trends into practical, actionable steps for enhanced market performance.
The Oncology Index gives your team clear visibility into how payers manage oncology therapies by revealing coverage policies, restrictions, and decision-making patterns across plans.
The Oncology Index uncovers evolving oncology market dynamics by tracking shifts in coverage, site-of-care preferences, and management of new and emerging therapies.
By translating payer behavior and coverage insights into actionable intelligence, the Oncology Index helps inform smarter market access and commercial strategies.
Key Insights From MMIT
Solutions to Support Your Strategy
Enhance the value of the Oncology Index with complementary solutions that offer your team enhanced visibility into payer behaviour, patient pathways, and the uptake of emerging therapies. With this broader perspective, you can translate insight into decisive, well-informed action across the oncology landscape.